Aortic Valve Replacement Market
Aortic Valve Replacement Market Size, Share & Trends Analysis Report by Disease (Aortic Stenosis and Aortic Regurgitation), by Device (Mechanical Heart Valves, Transcatheter Heart Valves, and Tissue Heart Valves), and by End User (Hospitals, Ambulatory Surgical Centers, and Others) Forecast Period, (2026-2035)
Industry Overview
Aortic valve replacement market valued at $10,803.5 million in 2025 and is projected to reach $23,797.7 million by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035). The global aortic valve replacement market is progressing steadily as healthcare systems prioritize advanced cardiac care solutions for managing structural heart diseases. Growth is being supported by the increasing prevalence of aortic stenosis, particularly among aging populations, alongside rising awareness regarding timely diagnosis and treatment. The shift toward minimally invasive procedures, including transcatheter approaches, is significantly transforming treatment pathways by reducing recovery time and procedural risk. Technological advancements in valve design, imaging guidance, and procedural techniques are further enhancing clinical outcomes. As healthcare providers emphasize improved patient quality of life and long-term durability of implants, aortic valve replacement solutions are becoming an essential component of modern cardiovascular care.
Market Dynamics
Rising Prevalence of Aortic Stenosis and Aging Population Driving Demand
The increasing global burden of cardiovascular diseases, particularly aortic stenosis, is a primary factor fueling demand for aortic valve replacement procedures. Aging demographics across developed and emerging economies are contributing to a higher incidence of degenerative valve disorders. Healthcare providers are focusing on early diagnosis and timely intervention to prevent complications such as heart failure. This trend is encouraging the adoption of both surgical and transcatheter valve replacement procedures. Additionally, improvements in diagnostic imaging and screening practices are enabling more patients to be identified and treated at earlier stages, thereby supporting consistent market growth.
Growing Adoption of Minimally Invasive and Transcatheter Procedures
The market is witnessing a significant transition from traditional open-heart surgeries to minimally invasive approaches such as transcatheter aortic valve replacement (TAVR). These procedures offer advantages including shorter hospital stays, reduced surgical trauma, and faster recovery times, making them particularly suitable for elderly and high-risk patients. Continuous innovation in catheter-based delivery systems and valve technologies is improving procedural success rates and expanding eligibility to intermediate- and low-risk patient groups. As clinical evidence supporting the safety and efficacy of TAVR continues to grow, its adoption is accelerating across global healthcare systems.
Expanding Healthcare Infrastructure and Access in Emerging Markets
Emerging economies are increasingly contributing to the growth of the aortic valve replacement market due to improvements in healthcare infrastructure and access to advanced cardiac treatments. Governments and private healthcare providers are investing in specialized cardiac centers and training programs to enhance procedural capabilities. Rising healthcare expenditure and expanding insurance coverage are also enabling a larger patient population to access valve replacement therapies. As awareness of advanced treatment options increases, these regions are expected to play a crucial role in the market’s long-term expansion.
Market Segmentation
- Based on the disease, the market is segmented into aortic stenosis and aortic regurgitation.
- based on the device, the market is segmented into mechanical heart valves, transcatheter heart valves, and tissue heart valves.
- based on the end user, the market is segmented into hospitals, ambulatory surgical centers, and others.
Transcatheter Heart Valves Segment to Dominate the Market with the Largest Share
In the global aortic valve replacement market, the transcatheter heart valves segment is expected to account for the largest market share, driven by the increasing adoption of minimally invasive procedures and growing preference for transcatheter aortic valve replacement (TAVR). These devices offer significant advantages over traditional surgical approaches, including reduced recovery time, lower risk of complications, and improved patient outcomes, particularly among elderly and high-risk patient populations. Technological advancements in valve design, improved delivery systems, and expanding clinical indications are further accelerating adoption across both developed and emerging markets. In addition, favorable reimbursement policies and increasing physician expertise in transcatheter procedures are reinforcing the segment’s leading position within the market.
Aortic Stenosis: A Key Segment in Market Growth
The aortic stenosis segment plays a pivotal role in driving growth within the aortic valve replacement market, owing to its high prevalence, especially among the aging population. This condition represents the most common indication for valve replacement procedures, as untreated severe aortic stenosis can lead to significant morbidity and mortality. Rising awareness, improved diagnostic capabilities, and increased screening rates are contributing to earlier detection and timely intervention. Furthermore, the growing availability of advanced treatment options, including both surgical and transcatheter approaches, is expanding access to care. These factors collectively position the aortic stenosis segment as a major contributor to overall market expansion.
Regional Outlook
The global aortic valve replacement market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Europe Strengthening Position Through Advanced Cardiac Care Programs
Europe is witnessing stable growth in the aortic valve replacement market, supported by well-established healthcare systems and a strong focus on cardiovascular disease management. The region benefits from widespread adoption of minimally invasive procedures and continuous advancements in medical device technologies. Collaborative research initiatives and clinical trials are further driving innovation in valve design and procedural techniques. Additionally, stringent regulatory frameworks ensure high standards of safety and efficacy, which is reinforcing patient and provider confidence in advanced valve replacement therapies.
North America Region Dominates the Market with Major Share
North America holds a dominant position in the aortic valve replacement market due to its advanced healthcare infrastructure and high adoption of innovative cardiac technologies. The presence of leading medical device companies and strong investment in research and development are accelerating the introduction of next-generation valve systems. Favorable reimbursement policies and early adoption of transcatheter procedures are further supporting market growth. Additionally, increasing prevalence of lifestyle-related cardiovascular conditions and strong clinical expertise are contributing to the region’s leadership in both procedural volume and technological advancement.
Market Players Outlook
The major companies operating in the global aortic valve replacement market includes Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Medtronic plc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In 2025, Edwards Lifesciences expanded its transcatheter heart valve portfolio with next-generation systems designed to improve durability and procedural precision, reinforcing its leadership in minimally invasive valve therapies.
- In 2025, Medtronic plc introduced advancements in its TAVR platform, focusing on enhanced delivery systems and improved patient outcomes, supporting broader adoption across diverse risk profiles.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global aortic valve replacement Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Aortic Valve Replacement Market Sales Analysis – Disease | Device | End User ($ Million)
- Aortic Valve Replacement Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Aortic Valve Replacement Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Aortic Valve Replacement Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Aortic Valve Replacement Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Aortic Valve Replacement Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Aortic Valve Replacement Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Aortic Valve Replacement Market Revenue and Share by Manufacturers
- Aortic Valve Replacement Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Abbott Laboratories
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Boston Scientific Corporation
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Edwards Lifesciences Corporation
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- LivaNova PLC
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Medtronic plc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership and Collaboration
- Abbott Laboratories
- Key Company Analysis
- Global Aortic Valve Replacement Market Sales Analysis by Disease ($ Million)
- Aortic Stenosis
- Aortic Regurgitation
- Global Aortic Valve Replacement Market Sales Analysis by Device ($ Million)
- Mechanical Heart Valves
- Transcatheter Heart Valves
- Tissue Heart Valves
- Global Aortic Valve Replacement Market Sales Analysis by End User ($ Million)
- Hospitals
- Ambulatory Surgical Centers
- Others
- Regional Analysis
- North American Aortic Valve Replacement Market Sales Analysis – Disease | Device | End User | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Aortic Valve Replacement Market Sales Analysis – Disease | Device | End User | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Aortic Valve Replacement Market Sales Analysis – Disease | Device | End User | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Aortic Valve Replacement Market Sales Analysis – Disease | Device | End User | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Abbott Laboratories
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Artivion, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Biotronik SE & Co. KG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boston Scientific Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Braile Biomedica
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Colibri Heart Valve, LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Corcym
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- CryoLife, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Edwards Lifesciences Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- JC Medical, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- JenaValve Technology, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lepu Medical Technology (Beijing) Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- LifeTech Scientific Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- LivaNova PLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Meril Life Sciences Pvt. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- MicroPort Scientific Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ningbo Jenscare Biotechnology Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Peijia Medical Limited
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Venus Medtech (Hangzhou) Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Abbott Laboratories
1. Global Aortic Valve Replacement Market Research and Analysis by Disease, 2025–2035 ($ Million)
2. Global Aortic Stenosis Valve Replacement Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Aortic Regurgitation Valve Replacement Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Aortic Valve Replacement Market Research and Analysis by Device, 2025–2035 ($ Million)
5. Global Aortic Mechanical Heart Valve Replacement Market Research and Analysis by Region, 2025–2035 ($ Million)
6. Global Aortic Transcatheter Heart Valve Replacement Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Aortic Tissue Heart Valve Replacement Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Aortic Valve Replacement Market Research and Analysis by End User, 2025–2035 ($ Million)
9. Global Aortic Valve Replacement for Hospitals Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Aortic Valve Replacement for Ambulatory Surgical Centers Market Research and Analysis by Region, 2025–2035 ($ Million)
11. Global Aortic Valve Replacement for Others Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Aortic Valve Replacement Market Research and Analysis by Region, 2025–2035 ($ Million)
13. North American Aortic Valve Replacement Market Research and Analysis by Country, 2025–2035 ($ Million)
14. North American Aortic Valve Replacement Market Research and Analysis by Disease, 2025–2035 ($ Million)
15. North American Aortic Valve Replacement Market Research and Analysis by Device, 2025–2035 ($ Million)
16. North American Aortic Valve Replacement Market Research and Analysis by End User, 2025–2035 ($ Million)
17. European Aortic Valve Replacement Market Research and Analysis by Country, 2025–2035 ($ Million)
18. European Aortic Valve Replacement Market Research and Analysis by Disease, 2025–2035 ($ Million)
19. European Aortic Valve Replacement Market Research and Analysis by Device, 2025–2035 ($ Million)
20. European Aortic Valve Replacement Market Research and Analysis by End User, 2025–2035 ($ Million)
21. Asia-Pacific Aortic Valve Replacement Market Research and Analysis by Country, 2025–2035 ($ Million)
22. Asia-Pacific Aortic Valve Replacement Market Research and Analysis by Disease, 2025–2035 ($ Million)
23. Asia-Pacific Aortic Valve Replacement Market Research and Analysis by Device, 2025–2035 ($ Million)
24. Asia-Pacific Aortic Valve Replacement Market Research and Analysis by End User, 2025–2035 ($ Million)
25. Rest of the World Aortic Valve Replacement Market Research and Analysis by Region, 2025–2035 ($ Million)
26. Rest of the World Aortic Valve Replacement Market Research and Analysis by Disease, 2025–2035 ($ Million)
27. Rest of the World Aortic Valve Replacement Market Research and Analysis by Device, 2025–2035 ($ Million)
28. Rest of the World Aortic Valve Replacement Market Research and Analysis by End User, 2025–2035 ($ Million)
1. Global Aortic Valve Replacement Market Share by Disease, 2025 Vs 2035 (%)
2. Global Aortic Stenosis Valve Replacement Market Share by Region, 2025 Vs 2035 (%)
3. Global Aortic Regurgitation Valve Replacement Market Share by Region, 2025 Vs 2035 (%)
4. Global Aortic Valve Replacement Market Research and Analysis by Device, 2025 Vs 2035 (%)
5. Global Aortic Mechanical Heart Valve Replacement Market Share by Region, 2025 Vs 2035 (%)
6. Global Aortic Transcatheter Heart Valve Replacement Market Share by Region, 2025 Vs 2035 (%)
7. Global Aortic Tissue Heart Valve Replacement Market Share by Region, 2025 Vs 2035 (%)
8. Global Aortic Valve Replacement Market Research and Analysis by End User, 2025 Vs 2035 (%)
9. Global Aortic Valve Replacement for Hospitals Market Share by Region, 2025 Vs 2035 (%)
10. Global Aortic Valve Replacement for Ambulatory Surgical Centers Market Share by Region, 2025 Vs 2035 (%)
11. Global Aortic Valve Replacement for Others Market Share by Region, 2025 Vs 2035 (%)
12. Global Aortic Valve Replacement Market Research and Analysis by Region, 2025–2035 ($ Million)
13. US Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
14. Canada Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
15. UK Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
16. France Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
17. Germany Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
18. Italy Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
19. Spain Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
20. Russia Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
21. Rest of Europe Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
22. India Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
23. China Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
24. Japan Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
25. South Korea Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
26. Australia and New Zealand Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
27. ASEAN Economies Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
28. Rest of Asia-Pacific Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
29. Latin America Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
30. Middle East and Africa Aortic Valve Replacement Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
